Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 1.500% 4/1
-
Number of holders
-
30
-
Total 13F principal, excl. options
-
219M
-
Principal change
-
-2.51M
-
Total reported value, excl. options
-
$145M
-
Value change
-
-$2.27M
-
Number of buys
-
8
-
Number of sells
-
-8
-
Price
-
$0.66
Significant Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2022
32 filings reported holding 19249HAB9 - COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2022.
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 has 30 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $219M of principal
.
Largest 10 bondholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC ($39.5M of principal), LAZARD ASSET MANAGEMENT LLC ($39.4M of principal), UBS ASSET MANAGEMENT AMERICAS INC ($21.5M of principal), COURAGE CAPITAL MANAGEMENT LLC ($18M of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($14.7M of principal), WOLVERINE ASSET MANAGEMENT LLC ($14.7M of principal), AQR Arbitrage LLC ($12.6M of principal), D. E. Shaw & Co., Inc. ($10M of principal), Calamos Advisors LLC ($5.82M of principal), and GABELLI FUNDS LLC ($5.6M of principal).
This table shows the top 30 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.